|
US20090298179A1
(en)
*
|
2003-04-29 |
2009-12-03 |
Connie Erickson-Miller |
Methods For Treating Degenerative Diseases/Injuries
|
|
JP4895807B2
(ja)
*
|
2003-04-29 |
2012-03-14 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
変性疾患／損傷の治療方法
|
|
US20090143453A1
(en)
*
|
2003-04-29 |
2009-06-04 |
Connie Erickson-Miller |
Methods for treating degenerative diseases/injuries
|
|
US20090048318A1
(en)
*
|
2003-04-29 |
2009-02-19 |
Connie Erickson-Miller |
Methods for treating degenerative diseases/injuries
|
|
US8354427B2
(en)
*
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
US7625890B2
(en)
*
|
2005-11-10 |
2009-12-01 |
Smithkline Beecham Corp. |
Substituted imidazo[4,5-c]pyridine compounds as Akt inhibitors
|
|
SI2455382T1
(sl)
*
|
2005-12-13 |
2017-03-31 |
Incyte Holdings Corporation |
S heteroarilom substituirani pirolo(2,3b)piridini in pirolo(2,3-b)pirimidini kot zaviralci janus kinaze
|
|
DK1962830T3
(da)
*
|
2005-12-23 |
2013-06-24 |
Glaxosmithkline Llc |
Azaindolhæmmere af aurorakinaser.
|
|
CN101405001A
(zh)
*
|
2006-03-20 |
2009-04-08 |
霍夫曼-拉罗奇有限公司 |
抑制btk和syk蛋白质激酶的方法
|
|
CL2007003244A1
(es)
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
MY154969A
(en)
|
2007-06-13 |
2015-08-28 |
Incyte Corp |
Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
AR070127A1
(es)
*
|
2008-01-11 |
2010-03-17 |
Novartis Ag |
Pirrolo - pirimidinas y pirrolo -piridinas
|
|
CA2722220C
(en)
|
2008-04-30 |
2016-06-07 |
National Health Research Institutes |
Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
|
|
CL2009001884A1
(es)
*
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
EP2344446A4
(en)
|
2008-10-17 |
2012-04-04 |
Akaal Pharma Pty Ltd |
S1P RECEPTOR MODULATORS
|
|
CN102186845B
(zh)
*
|
2008-10-17 |
2016-09-07 |
阿卡制药有限公司 |
S1p受体调节剂以及它们的用途
|
|
DE102008052943A1
(de)
|
2008-10-23 |
2010-04-29 |
Merck Patent Gmbh |
Azaindolderivate
|
|
EP2198710A1
(de)
|
2008-12-19 |
2010-06-23 |
Bayer CropScience AG |
Verwendung von 5-Pyridin-4yl-(1,3)Thiazole zur Bekämpfung phytopathogener Pilze
|
|
CA2747326C
(en)
|
2008-12-22 |
2017-05-16 |
Millennium Pharmaceuticals, Inc. |
Combination of aurora kinase inhibitors and anti-cd20 antibodies
|
|
US20110288142A1
(en)
*
|
2009-01-30 |
2011-11-24 |
Chen Pingyun Y |
CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
|
|
JO3635B1
(ar)
|
2009-05-18 |
2020-08-27 |
Millennium Pharm Inc |
مركبات صيدلانية صلبة وطرق لانتاجها
|
|
JP5775070B2
(ja)
*
|
2009-05-22 |
2015-09-09 |
インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ |
ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体
|
|
NZ596374A
(en)
*
|
2009-05-22 |
2014-01-31 |
Incyte Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
JO3434B1
(ar)
|
2009-07-31 |
2019-10-20 |
Millennium Pharm Inc |
مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
|
|
EP2470533A4
(en)
|
2009-08-24 |
2013-01-23 |
Ascepion Pharmaceuticals Inc |
UREA COMPOUNDS CONTAINING A 5,6-BICYCLIC HETEROARYL GROUP
|
|
WO2011028685A1
(en)
*
|
2009-09-01 |
2011-03-10 |
Incyte Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
EP2308866A1
(de)
*
|
2009-10-09 |
2011-04-13 |
Bayer CropScience AG |
Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
|
|
AU2010303270A1
(en)
|
2009-10-09 |
2012-05-03 |
Zafgen Corporation |
Sulphone compounds for use in the treatment of obesity
|
|
CN104031049A
(zh)
|
2010-02-19 |
2014-09-10 |
米伦纽姆医药公司 |
极光激酶抑制剂的结晶形式
|
|
SMT202000373T1
(it)
*
|
2010-03-10 |
2020-09-10 |
Incyte Holdings Corp |
Piperidin-4-il azetidin derivati come inibitori di jak1
|
|
WO2011143669A2
(en)
|
2010-05-14 |
2011-11-17 |
Dana-Farber Cancer Institute, Inc |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
|
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
|
EP2569434B1
(en)
|
2010-05-14 |
2019-09-04 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating leukemia and related disorders
|
|
SG10201910912TA
(en)
|
2010-05-21 |
2020-01-30 |
Incyte Corp |
Topical Formulation for a JAK Inhibitor
|
|
KR20130043207A
(ko)
|
2010-07-22 |
2013-04-29 |
자프겐 인크. |
트리시클릭 화합물 및 이의 제조 및 사용 방법
|
|
EA026201B1
(ru)
|
2010-11-19 |
2017-03-31 |
Инсайт Холдингс Корпорейшн |
Циклобутилзамещенные производные пирролопиридина и пирролопиримидина как ингибиторы jak
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
JP6058557B2
(ja)
|
2011-01-26 |
2017-01-11 |
ザフゲン，インコーポレイテッド |
テトラゾール化合物ならびにその作製方法および使用方法
|
|
CA2835195A1
(en)
|
2011-05-06 |
2012-11-15 |
Zafgen, Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
KR20140040739A
(ko)
|
2011-05-06 |
2014-04-03 |
자프겐 인크. |
삼환식 피라졸 설폰아마이드 화합물 그리고 그의 제조방법 및 그를 이용하는 방법
|
|
EA025526B1
(ru)
|
2011-05-06 |
2017-01-30 |
Зафджен Инк. |
Частично насыщенные трициклические соединения и способы их получения и применения
|
|
BR112013032720A2
(pt)
|
2011-06-20 |
2016-09-13 |
Incyte Corp |
"derivados de azetidinil fenil, piridil ou pirazinil carboxamida como inibidores de jak, composição e uso dos referidos derivados"
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
KR20140112565A
(ko)
|
2012-01-18 |
2014-09-23 |
자프겐 인크. |
삼환식 설폰아마이드 화합물 그리고 그의 제조방법 및 그를 이용하는 방법
|
|
CA2861381A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfone compounds and methods of making and using same
|
|
US20130303519A1
(en)
|
2012-03-20 |
2013-11-14 |
Millennium Pharmaceuticals, Inc. |
Methods of treating cancer using aurora kinase inhibitors
|
|
WO2013173720A1
(en)
|
2012-05-18 |
2013-11-21 |
Incyte Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
EA025186B1
(ru)
|
2012-06-29 |
2016-11-30 |
Пфайзер Инк. |
НОВЫЕ 4-(ЗАМЕЩЕННЫЙ АМИНО)-7Н-ПИРРОЛО[2,3-d]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LRRK2
|
|
CN103664936A
(zh)
*
|
2012-09-17 |
2014-03-26 |
杨育新 |
一类治疗创伤性脑损伤疾病的化合物及其用途
|
|
CN103800345A
(zh)
*
|
2012-11-02 |
2014-05-21 |
常辉 |
一类治疗精神分裂症的化合物及其用途
|
|
MX2015005734A
(es)
|
2012-11-05 |
2016-02-10 |
Zafgen Inc |
Metodos de tratamiento de enfermedades hepaticas.
|
|
EP2925737B1
(en)
|
2012-11-05 |
2017-06-14 |
Zafgen, Inc. |
Tricyclic compounds for use in the treatment and/or control of obesity
|
|
US10174009B2
(en)
|
2012-11-05 |
2019-01-08 |
Zafgen, Inc. |
Tricyclic sulphonamide compounds and methods of making and using same
|
|
IL291391B
(en)
|
2012-11-15 |
2022-11-01 |
Incyte Holdings Corp |
Sustained-release dosage forms of ruxolitinib
|
|
EP2961746B1
(en)
|
2013-02-28 |
2018-01-03 |
Bristol-Myers Squibb Company |
Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
|
|
AR094929A1
(es)
|
2013-02-28 |
2015-09-09 |
Bristol Myers Squibb Co |
Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
|
|
EA201891157A1
(ru)
|
2013-03-06 |
2019-02-28 |
Инсайт Холдингс Корпорейшн |
Способы и промежуточные соединения при получении ингибитора jak
|
|
TW201444836A
(zh)
*
|
2013-03-14 |
2014-12-01 |
Abbvie Inc |
吡咯并［２，３－ｂ］吡啶ｃｄｋ９激酶抑制劑
|
|
BR112015023356A2
(pt)
|
2013-03-14 |
2017-07-18 |
Abbvie Inc |
inibidores de quinase pirrol[2,3-b]piridina cdk9
|
|
CA2907726A1
(en)
|
2013-03-22 |
2014-09-25 |
Millennium Pharmaceuticals, Inc. |
Combination of catalytic mtorc1/2 inhibitors and selective inhibitors of aurora a kinase
|
|
KR20160034379A
(ko)
|
2013-07-25 |
2016-03-29 |
다나-파버 캔서 인스티튜트 인크. |
전사 인자의 억제제 및 그의 용도
|
|
SG10201801069QA
(en)
|
2013-08-07 |
2018-03-28 |
Incyte Corp |
Sustained release dosage forms for a jak1 inhibitor
|
|
MX2016005980A
(es)
|
2013-11-08 |
2016-12-09 |
Dana Farber Cancer Inst Inc |
Terapia de combinación para el cáncer usando inhibidores de la proteína bromodominio y extra-terminal.
|
|
EP3083618B1
(en)
|
2013-12-17 |
2018-02-21 |
Pfizer Inc |
Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
|
|
CN106029653A
(zh)
|
2014-01-31 |
2016-10-12 |
达纳-法伯癌症研究所股份有限公司 |
二氨基嘧啶苯砜衍生物及其用途
|
|
US10793571B2
(en)
|
2014-01-31 |
2020-10-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
MX2016011160A
(es)
|
2014-02-28 |
2017-04-27 |
Tensha Therapeutics Inc |
Tratamiento de afecciones asociadas con la hiperinsulinemia.
|
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
|
EP3177626A4
(en)
|
2014-08-08 |
2017-12-27 |
Dana Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
WO2016022970A1
(en)
|
2014-08-08 |
2016-02-11 |
Dana-Farber Cancer Institute, Inc. |
Dihydropteridinone derivatives and uses thereof
|
|
SG11201703414VA
(en)
|
2014-10-27 |
2017-05-30 |
Tensha Therapeutics Inc |
Bromodomain inhibitors
|
|
BR112017017135A2
(pt)
*
|
2015-03-02 |
2018-04-03 |
Rigel Pharmaceuticals, Inc. |
inibidores de tgf-beta
|
|
WO2016201370A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
EP3324976A4
(en)
|
2015-07-21 |
2019-03-27 |
Millennium Pharmaceuticals, Inc. |
ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
|
|
UA123946C2
(uk)
|
2015-09-11 |
2021-06-30 |
Дана-Фарбер Кенсер Інстітьют, Інк. |
Ацетамідтієнотриазолодіазепіни й шляхи їх застосування
|
|
SG10202007090UA
(en)
|
2015-09-11 |
2020-08-28 |
Dana Farber Cancer Inst Inc |
Cyano thienotriazolodiazepines and uses thereof
|
|
CN108137586B
(zh)
|
2015-09-14 |
2021-04-13 |
辉瑞大药厂 |
作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
|
|
JP7385356B2
(ja)
|
2015-11-25 |
2023-11-22 |
ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド |
二価ブロモドメインインヒビターおよびそれらの使用
|
|
AR113922A1
(es)
|
2017-12-08 |
2020-07-01 |
Incyte Corp |
Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
|
|
HRP20220510T1
(hr)
|
2018-01-30 |
2022-05-27 |
Incyte Corporation |
Postupci za pripravu (1-(3-fluoro-2-(trifluorometil)izonikotinil) piperidin-4-ona)
|
|
EP4424328A3
(en)
|
2018-03-30 |
2024-12-04 |
Incyte Corporation |
Treatment of hidradenitis suppurativa using jak inhibitors
|
|
US20220218831A1
(en)
*
|
2019-05-01 |
2022-07-14 |
Nemucore Medical Innovations, Inc. |
Degradation of aurora kinase (aurk) by conjugation of aurk inhibitors with e3 ligase ligand
|
|
CN114008046B
(zh)
*
|
2019-06-27 |
2023-08-18 |
南京明德新药研发有限公司 |
作为cdk9抑制剂的氮杂吲哚连吡唑类化合物
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
CN112225723B
(zh)
*
|
2020-12-16 |
2021-03-30 |
北京华氏开元医药科技有限公司 |
一种吲哚类衍生物、制备方法及应用
|
|
WO2022135580A1
(zh)
*
|
2020-12-25 |
2022-06-30 |
南京明德新药研发有限公司 |
吡啶并吡咯类化合物的晶型、制备方法及其应用
|
|
CN115572294B
(zh)
*
|
2022-11-13 |
2023-11-21 |
药康众拓(江苏)医药科技有限公司 |
一种氘代氮杂吲哚联吡唑类化合物、药物组合物和用途
|